跳到正文
原文
Medical Xpress·· 2026-10-21精选AI 评分75

早期类风湿关节炎达标治疗10年随访:82%患者处于DAS缓解

Favorable long-term outcomes seen with treat-to-target strategy in early rheumatoid arthritis

AI 导读

挪威Diakonhjemmet医院研究团队报告,ARCTIC试验中230例早期类风湿关节炎患者接受2年严格达标治疗后,10年随访时82%处于DAS缓解。10年间影像学进展有限,van der Heijde改良Sharp评分自基线至10年的中位变化为2.0,身体功能与健康相关生活质量明显改善并接近人群常模。

推荐理由

10年随访把早期RA达标治疗的缓解、身体功能与生存结局放在同一时间轴上,便于评估长期管理预期。

正文
rheumatoid arthritis
Credit: Unsplash/CC0 Public Domain

For patients with early rheumatoid arthritis (RA) managed with a treat-to-target strategy, achievement of sustained remission at two years is associated with higher remission rates and better physical function at 10 years, according to a study published online Oct. 15 in Annals of the Rheumatic Diseases.

Lena Bugge Nordberg, M.D., Ph.D., from Diakonhjemmet Hospital in Norway, and colleagues enrolled 230 patients from the ARCTIC trial with early RA to examine whether achievement of sustained remission is associated with favorable long-term outcomes. A strict treat-to-target strategy was applied for two years; participants were invited to a 10-year follow-up, including assessment of disease activity, radiographic damage, physical function, and survival.

Overall, 218 of the patients were alive at 10 years and 179 (82%) participated in the follow-up study. The researchers found that at 10 years after diagnosis, 82% of patients were in disease activity score (DAS) remission. Limited radiographic progression was seen, with a median change of 2.0 in the total van der Heijde-modified Sharp score from baseline to 10 years.

Substantial improvement was seen in physical function and health-related quality of life, approaching population norms. Comparable survival was seen to that of the general population. Lower disease activity and higher physical function were seen at the 10-year follow-up for patients who achieved sustained DAS remission at two years versus those who did not.

"The results support current treatment recommendations for RA and offer reassurance to patients newly diagnosed with RA that clinical remission, preserved function, and favorable long-term survival are realistic long-term outcomes," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Publication details

Lena Bugge Nordberg et al., Ten-year outcomes after treat-to-target therapy in early rheumatoid arthritis, Annals of the Rheumatic Diseases (2026). DOI: 10.1016/j.ard.2026.09.003

Journal information: Annals of the Rheumatic Diseases

Key medical concepts

Physical Function

Clinical categories

Rheumatology

Who's behind this story?

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Copyright © 2026 HealthDay. All rights reserved.

Citation: Favorable long-term outcomes seen with treat-to-target strategy in early rheumatoid arthritis (2026, October 20) retrieved 20 October 2026 from https://medicalxpress.com/news/2026-10-favorable-term-outcomes-strategy-early.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com